Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway

Abstract

Although several studies confirmed that berberine may attenuate airway inflammation in mice with chronic obstructive pulmonary disease (COPD), its underlying mechanisms were not clear until now. We aimed to establish an experiment mouse model for COPD and to investigate the effects of berberine on airway inflammation and its possible mechanism in COPD model mice induced by cigarette smoke extract (CSE). Twenty SPF C57BL/6 mice were randomly divided into PBS control group, COPD model group, low-dose berberine group and high-dose berberine group, 5 mice in each group. The neutrophils and macrophages were examined by Wright’s staining. The levels of inflammatory cytokines TNF-α and IL-6 in bronchoalveolar lavage fluid (BALF) were determined by enzyme-linked immunosorbent assay. The expression levels of TGF-β1, Smad2 and Smad3 mRNA and proteins in lung tissues were respectively detected by quantitative real-time polymerase chain reaction and Western blotting. It was found that CSE increased the number of inflammation cells in BALF, elevated lung inflammation scores, and enhanced the TGF-β1/Smads signaling activity in mice. High-dose berberine restrained the alterations in the COPD mice induced by CSE. It was concluded that high-dose berberine ameliorated CSE-induced airway inflammation in COPD mice. TGF-β1/Smads signaling pathway might be involved in the mechanism. These findings suggested a therapeutic potential of high-dose berberine on the CSE-induced airway inflammation.

Keywords

berberine / cigarette smoke extract / chronic obstructive pulmonary disease / TGF-β1/ Smads signaling pathway

References

[1] VogelmeierCF, CrinerGJ, MartinezFJ, et al.. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. Am J Respir Crit Care Med, 2017, 195(5): 557-582

[2] MunSY, HwangYI, KimJH, et al.. Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey. Korean J Intern Med, 2015, 30(2): 191-197

[3] ChurgA, CosioM, WrightJL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol, 2008, 294(4): 612-31

[4] YangZS, YanJY, HanNP, et al.. Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD. Iran J Basic Med Sci, 2016, 19(9): 993-1002

[5] FergusonGT, CalverleyPM, AndersonJA, et al.. Prevalence and Progression of Osteoporosis in Patients With COPD: Results From the Towards a Revolution in COPD Health Study. Chest, 2009, 136(6): 1456-1465

[6] EurichDT, LeeC, MarrieTJ, et al.. Inhaled Corticosteroids and Risk of Recurrent Pneumonia: A Population-Based, Nested Case-Control Study. Clin Infect Dis, 2013, 57(8): 1138-1144

[7] O’ByrnePM, RennardS, GersteinH, et al.. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir Med, 2012, 106(11): 1487-1493

[8] NiWJ, DingHH, TangLQ. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. Eur J Pharmacol, 2015, 760: 103-112

[9] PengL, KangS, YinZ, et al.. Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. Int J Clin Exp Pathol, 2015, 8(5): 5217-5223

[10] VuddandaPR, ChakrabortyS, SinghS. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs, 2010, 19(10): 1297-1307

[11] WangZ, ChenZ, YangS, et al.. Berberine Ameliorates Collagen-Induced Arthritis in Rats Associated with Anti-inflammatory and Anti-angiogenic Effects. Inflammation, 2014, 37(5): 1789-1798

[12] TillhonM, Guamán OrtizLM, LombardiP, et al.. Berberine: new perspectives for old remedies. Biochem Pharmacol, 2012, 84(10): 1260-1267

[13] LinK, LiuS, ShenY, et al.. Berberine attenuates cigarette smoke-induced acute lung inflammation. Inflammation, 2013, 36(5): 1079-1086

[14] XuD, WanC, WangT, et al.. Berberine attenuates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice. Int J Clin Exp Med, 2015, 8(6): 8641-8647

[15] Nana-SinkamSP, LeeJD, Sotto-SantiagoS, et al.. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med, 2007, 175(7): 676-685

[16] ZhangY, CaoJ, ChenY, et al.. Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice. Exp Lung Res, 2013, 39(1): 18-31

[17] WoodsJA, WheelerJS, FinchCK, et al.. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2014, 9: 421-430

[18] SilvaOR, MontesJF, García-ValeroJ, et al.. Cellular effectors of the inflammatory response in chronic obstructive pulmonary disease (COPD). Rev Med Chil, 2015, 143(9): 1162-1171

[19] BafadhelM, McCormickM, SahaS, et al.. Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary Disease. Respiration, 2012, 83(1): 36-44

[20] HuangAX, LuLW, LiuWJ, et al.. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome. Med Sci Monit, 2016, 22: 2800-2808

[21] LeeTM, LinMS, ChangNC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol, 2008, 101(4): 530-535

[22] LiangR, ZhangW, SongY. Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models. Mol Med Rep, 2013, 7(5): 1470-1476

[23] FerrariR, TanniSE, CaramLM, et al.. Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res, 2013, 14(1): 24

[24] YuSY, GaoXW, YanZJ. Relationship between gene polymorphisms of tumor necrosis factor-α-308 and phenotypes of acute exacerbation of chronic obstructive pulmonary diseases. Chin J Tuberc Respir Dis, 2016, 39(3): 203-207

[25] ChiangCH, ChuangCH, LiuSL. Transforming growth factor-βl and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner. Lung, 2014, 192(1): 95-102

[26] MorrisDG, HuangX, KaminskiN, et al.. Loss of integrin alpha v beta 6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature, 2003, 422(6928): 169-173

[27] VerhammeFM, BrackeKR, JoosGF, et al.. TGF-β Superfamily in Obstructive Lung Diseases: More Suspects than TGF-β Alone. Am J Respir Cell Mol Biol, 2014, 52(6): 653-662

[28] SuZG, WenFQ, FengYL, et al.. Transforming growth factor-βl gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin, 2005, 26(6): 714-720

[29] MortyRE, KönigshoffM, EickelbergO. Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2009, 6(7): 607-613

[30] PodowskiM, CalviC, MetzgerS, et al.. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest, 2011, 122(1): 229-240

[31] ChungKF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005, 2(4): 371-372

[32] YangYC, ZhangN, Van CrombruggenK, et al.. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy, 2012, 67(10): 1193-1202

[33] HalwaniR, Al-MuhsenS, Al-JahdaliH, et al.. Role of transforming growth factor-β in airway remodeling in asthma. Am J Respir Cell Mol Biol, 2011, 44(2): 127-133

[34] ChitraP, SaiprasadG, ManikandanR, et al.. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. J Mol Med, 2015, 93(9): 1015-1031

[35] LiL, HuangW, LiK, et al.. Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway. Oncotarget, 2015, 6(41): 43 605-43 619

[36] LiY, LiJS, LiWW, et al.. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-KB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med, 2014, 14(1): 140